Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,939 | 492 | 77.0% |
| Consulting Fee | $2,778 | 1 | 17.9% |
| Travel and Lodging | $548.26 | 3 | 3.5% |
| Education | $235.42 | 4 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $3,620 | 39 | $0 (2024) |
| Astellas Pharma US Inc | $1,825 | 75 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $1,037 | 30 | $0 (2024) |
| AngioDynamics, Inc. | $873.50 | 7 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $678.00 | 27 | $0 (2024) |
| COLOPLAST CORP | $563.11 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $541.99 | 21 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $482.61 | 25 | $0 (2024) |
| ABBVIE INC. | $442.39 | 28 | $0 (2024) |
| Boston Scientific Corporation | $397.67 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,169 | 72 | Dendreon Pharmaceuticals LLC ($376.08) |
| 2023 | $4,869 | 74 | Janssen Biotech, Inc. ($2,986) |
| 2022 | $1,814 | 59 | AngioDynamics, Inc. ($576.62) |
| 2021 | $1,535 | 71 | Astellas Pharma US Inc ($220.00) |
| 2020 | $1,040 | 40 | Astellas Pharma US Inc ($212.45) |
| 2019 | $1,021 | 50 | Astellas Pharma US Inc ($265.73) |
| 2018 | $1,566 | 75 | Astellas Pharma US Inc ($403.91) |
| 2017 | $1,486 | 59 | Astellas Pharma US Inc ($526.50) |
All Payment Transactions
500 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $34.44 | General |
| Category: Oncology | ||||||
| 12/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: NONE | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: UROLOGY | ||||||
| 12/02/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: HORMONE THERAPY | ||||||
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: ONCOLOGY | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: HORMONE THERAPY | ||||||
| 09/11/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $17.45 | General |
| 09/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 08/29/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/26/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: OS | ||||||
| 08/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/21/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $48.51 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/14/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $22.95 | General |
| 08/12/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: UROLOGY | ||||||
| 08/02/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: UROLOGY | ||||||
| 07/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,777 | 10,438 | $778,467 | $213,015 |
| 2022 | 30 | 2,696 | 9,876 | $826,018 | $190,344 |
| 2021 | 30 | 2,786 | 17,305 | $1.0M | $303,650 |
| 2020 | 33 | 2,968 | 20,613 | $937,159 | $267,295 |
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 559 | 747 | $171,810 | $60,890 | 35.4% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 18 | 882 | $220,500 | $55,965 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 164 | 206 | $61,800 | $25,328 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 206 | 224 | $33,600 | $13,222 | 39.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 55 | 57 | $22,800 | $9,689 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $21,700 | $6,560 | 30.2% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 30 | 30 | $31,500 | $5,501 | 17.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $13,050 | $4,417 | 33.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 13 | $18,200 | $3,956 | 21.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 745 | 1,144 | $22,880 | $3,538 | 15.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 291 | 405 | $6,075 | $3,386 | 55.7% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 45 | 46 | $37,950 | $3,349 | 8.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 24 | $9,000 | $3,019 | 33.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 26 | 26 | $9,750 | $2,425 | 24.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 267 | 347 | $17,350 | $2,363 | 13.6% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2023 | 12 | 16 | $32,800 | $2,038 | 6.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $5,700 | $1,689 | 29.6% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 25 | 33 | $21,450 | $1,599 | 7.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 25 | 37 | $2,775 | $842.54 | 30.4% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 37 | 46 | $2,300 | $835.20 | 36.3% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 49 | 5,902 | $4,427 | $689.88 | 15.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 27 | 27 | $2,025 | $662.04 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 56 | $2,800 | $525.46 | 18.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 15 | 15 | $6,000 | $509.30 | 8.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 45 | $225.00 | $16.78 | 7.5% |
About John Britton, M. D
John Britton, M. D is a Urology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356394126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Britton, M. D has received a total of $15,500 in payments from pharmaceutical and medical device companies, with $2,169 received in 2024. These payments were reported across 500 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($11,939).
As a Medicare-enrolled provider, Britton has provided services to 11,227 Medicare beneficiaries, totaling 58,232 services with total Medicare billing of $974,304. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Charleston, SC
- Active Since 05/19/2006
- Last Updated 02/17/2017
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1356394126
Products in Payments
- ERLEADA (Drug) $3,246
- PROVENGE (Drug) $1,037
- XTANDI (Drug) $982.14
- NANOKNIFE (Device) $805.14
- XIAFLEX (Biological) $678.75
- BOTOX (Biological) $493.25
- KEYTRUDA (Biological) $476.21
- Myrbetriq (Drug) $382.74
- Nubeqa (Drug) $308.18
- Xtandi (Drug) $268.01
- Erleada (Drug) $260.23
- TITAN (Device) $255.32
- GEMTESA (Drug) $233.22
- UROLIFT (Device) $228.32
- Titan (Device) $215.61
- AQUABEAM SYSTEM (Device) $203.04
- MYRBETRIQ (Drug) $202.23
- JELMYTO (Drug) $183.03
- Xofigo (Drug) $174.43
- ORGOVYX (Drug) $168.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Charleston
Eric Rovner, Md, MD
Urology — Payments: $367,935
Dr. Sandip Prasad, Md, Mphil, MD, MPHIL
Urology — Payments: $102,389
Dr. Ian Marshall, M. D, M. D
Urology — Payments: $71,598
Dr. Thomas Keane, Md, MD
Urology — Payments: $70,386
Stephen Savage, Md, MD
Urology — Payments: $29,716
John Adams, Md, MD
Urology — Payments: $21,374